COVID IS EXTREMELY DANGEROUS FOR CHOLESTEROL AND HEART PATIENTS

COVID IS EXTREMELY DANGEROUS FOR CHOLESTEROL AND HEART PATIENTS- 

Speculation with respect to poorer outcomes for those with huge cholesterol and/or heart disease affected with SARS-CoV-2 are well known. This week, a real-world study published by the FH Foundation confirms COVID-19 enlarged heart attack rates accordingly in patients with these conditions. Familial hypercholesterolemia is a familiar yet severely underdiagnosed genetic condition. While those with large cholesterol are commonly considered to be elevated due to age, lifestyle, and diet, FH patients experience elevated LDL from birth. Researchers say only 10% of the estimated 1.3 million with FH have accepted a diagnosis due to lack of awareness. The condition raises the risk of cardiovascular disease by up to 20-fold due to the permanent elevation of LDL cholesterol. Adopting a machine learning process dubbed "FIND FH," the FH Foundation inspected a share of over 55.4 million individuals – those with diagnosed FH, probable FH, and atherosclerotic cardiovascular disease (ASCVD) - with and without COVID-19 infection. 

The study begins that the "probable FH" individuals with pre-existing ASCVD affected with COVID experienced heart attacks at the maximum rate, seven times larger than those who did not get the virus.  

These results are powerful because these data underscore the attention of awareness if individuals have underlying cardiovascular disease or genetic soaring cholesterol when handling COVID-19 infection or considering vaccination.

According to one author of the study, the "probable FH" patients are attainable not to acquire lipid-lowering treatment. Genetic soaring cholesterol cannot be well-managed by diet and exercise alone. 

This research is a call to action to diagnose individuals with this bloody genetic condition who are hiding in plain sight within our healthcare system and take distinct precautions detailing Covid-19 infections. In November, BioSpace announces a JAMA investigation that proved COVID-19 is a cardiac condition as it is a respiratory disease. SARS-CoV-2 causes heart destruction in 20% of people with mild or no symptoms. Many medications are accessible for the treatment of FH. The key is diagnosis. Additionally, individuals with FH and ASVCD should take extra care to avoid contracting the novel coronavirus, which has swept our globe for well over a year. Vaccinations are readily accessible in many countries and growing into those less accessible areas as well.  The CDC is planning to meet to regulate if COVID-19 vaccines will need boosters to support avoid the circulate of variants, some of which have changed into more poisonous and more deadly than the authentic strain.